SUBSCRIBE
SUBSCRIBE

Barinthus Biotherapeutics

NEWS
Life Science's Fastest Growing Job Right Now
Meet the UK Biotech Developing a Vaccine for Every Type of Flu
The company says the vaccine takes a novel approach.
February 6, 2018
 · 
1 min read
Load More
JOBS
IN THE PRESS
Business
Vaccitech Appoints Industry Veteran, Nadège Pelletier, Ph.D., as Chief Scientific Officer
January 30, 2023
 · 
4 min read
Vaccitech to Host KOL Webinar on the SNAPvax™ Platform for Inducing Tolerance to Treat Celiac and other Autoimmune Diseases
November 21, 2022
 · 
5 min read
Business
Vaccitech Reports Third Quarter 2022 Financial Results and Recent Corporate Developments
November 10, 2022
 · 
14 min read
Vaccitech to Present at Upcoming November 2022 Investors Conferences
November 9, 2022
 · 
2 min read
Vaccitech Provides Update on Ongoing VTP-300 Phase 1b/2a Trial Showing Sustained Reductions of HBsAg in Patients with Chronic Hepatitis B
November 7, 2022
 · 
8 min read
Drug Development
Vaccitech Announces Late-Breaker Abstract Accepted for Presentation at AASLD - The Liver Meeting® Providing Update on the Phase 1b/2a Study of VTP-300
November 2, 2022
 · 
3 min read
Drug Development
Vaccitech Doses First Patients in HBV003, a Phase 2b Clinical Trial of VTP-300 immunotherapeutic candidate for Chronic HBV Patients
October 31, 2022
 · 
5 min read
Publication in Cell Shows That Vaccitech’s SNAPvax™ Has the Potential to Treat Cancer by Reversing Suppressive Tumor Microenvironment with Novel “Vax-Innate” Paradigm
October 27, 2022
 · 
6 min read
Vaccitech to Present at Upcoming October 2022 Investor & Scientific Conferences
October 3, 2022
 · 
2 min read
Business
Vaccitech Promotes Gemma Brown as Chief Financial Officer
September 20, 2022
 · 
4 min read
Load More